ArticleDiscover oncology2026

Plasma interleukin-8 as a predictive biomarker for tyrosine kinase inhibitor response in advanced hepatocellular carcinoma.

Sujin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.